Project Grant R01NS138147

Award Date 8/15/24
Completion Date 7/31/29
Dollars Obligated $473K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The National Institute of Child Health and Human Development (NICHD) awarded a $481,250 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Oregon Health & Science University (OHSU). The grant, awarded on September 1, 2024, will support research to investigate the mechanisms of neuroinflammation and perinatal brain injury associated with intrauterine infection by the bacteria Ureaplasma parvum. Specifically, the project aims to assess...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $635,386.00 to Duke University to conduct research on the pathogenic mechanisms of inflammatory subventricular zone injury in preterm infants. The key objectives of this 5-year research project are to: 1) Define the immune signatures associated with the development of...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to optimize neuroprotective strategies for hypoxic-ischemic encephalopathy (HIE) in low- and middle-income countries (LMICs). The $615,478 award, effective June 18, 2025 through February 28, 2030, will support research to: 1) Determine the regional specificity and efficacy of multiple promising...
This Project Grant award of $260,887 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) will fund research at The Children's Hospital of Philadelphia (CHOP) to study the effects of chronic in utero hypoxia on the placenta, brain, and epigenome. The research team will leverage expertise in neuroscience, imaging, pathology, and placental biology to conduct 4D in utero MRI studies (4D-UMRI) to examine the...
This $444,125.00 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will be used by the University of California, San Francisco (UCSF) to conduct research on the brain maturation-dependent mechanisms underlying hemorrhagic transformation after delayed reperfusion in perinatal and childhood ischemic stroke. The key objectives are to: 1)...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $420,744 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to Oregon Health & Science University (OHSU). The purpose of this 2-year award, with a performance period from June 1, 2025 to May 31, 2027, is to develop a methodology for simultaneously analyzing adenosine-to-inosine (A-to-I) RNA editing in targeted transcripts and...
This $779,911 Project Grant awarded by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) aims to evaluate the impact of a music-based intervention (MBI) on preterm infant stress, brain development, and long-term neurodevelopmental outcomes. The MBI will be delivered to preterm infants in the neonatal intensive care unit (NICU) between 32-40 weeks gestation, with outcomes assessed during the NICU stay and up to 2...
This $546,094 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to understand the mechanisms underlying brain folding in human infants. The primary award to the Trustees of Indiana University will use longitudinal MRI data from preterm infants and fetuses to assess whether patterns of cortical expansion align with gradients of...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is focused on investigating the role of the GSX2 transcription factor in the development of neuronal circuits that regulate breathing in newborns. The $148,880 award to the Children's Hospital Medical Center in Cincinnati, Ohio will support research aims to characterize the temporal requirements of GSX2 in the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, provides $212,895 to Duke University to investigate the cell-type basis of the intratelencephalic (IT) neuron projection system and its dysregulation following perinatal hypoxic ischemic encephalopathy (HIE). The research, funded under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $472,616 to Oregon Health & Science University (OHSU) to conduct research on mechanisms underlying memory impairment in preterm infants experiencing acute respiratory failure.

The project aims to 1) determine if neonatal hypoxia disrupts hippocampal neuronal maturation independent of inflammation, neurodegeneration or white matter injury; 2) identify novel molecular mechanisms of hippocampal dysmaturation using single-nucleus RNA sequencing; and 3) evaluate the effects of neonatal hypoxia on excitatory and inhibitory synaptic transmission in the hippocampus and its impact on learning and memory. The research will leverage OHSU's expertise in neuroscience, neurological disorders, and advanced microscopy techniques to advance understanding of the persistent cognitive deficits observed in preterm infants and explore potential therapeutic interventions.

Generated 7/1/25, 2:26 AM